Sign Up to like & get
recommendations!
0
Published in 2023 at "International Journal of Developmental Neuroscience"
DOI: 10.1002/jdn.10255
Abstract: Myelin oligodendrocyte glycoprotein antibody‐associated disorders (MOGAD) is identified autoimmune disorder with a predominance in paediatric patients, and the disease spectrum has expanded with clinical and radiological patterns. The aim of the study was to describe…
read more here.
Keywords:
antibody associated;
glycoprotein antibody;
first attack;
associated disorders ... See more keywords
Sign Up to like & get
recommendations!
1
Published in 2020 at "Journal of Neuroimmunology"
DOI: 10.1016/j.jneuroim.2020.577168
Abstract: We aimed in this study to elucidate the impact of serum AQP4-IgG titer before starting treatments to the clinical manifestation of neuromyelitis optica spectrum disorders (NMOSD). Serum titer at the onset, measured using live cell-based…
read more here.
Keywords:
spectrum disorders;
neuromyelitis optica;
first attack;
optica spectrum ... See more keywords
Sign Up to like & get
recommendations!
1
Published in 2020 at "Journal of Clinical Neuroscience"
DOI: 10.1016/j.jocn.2020.02.017
Abstract: Predictors of attack location in relapsing-remitting multiple sclerosis (RRMS) are poorly known. It has been suggested that the site of the first relapse may influence the location of the subsequents. We aimed to ascertain this…
read more here.
Keywords:
location;
location first;
first attack;
multiple sclerosis ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2021 at "Frontiers in Neurology"
DOI: 10.3389/fneur.2021.667651
Abstract: Background: Many patients with neuromyelitis optica spectrum disorders (NMOSD) experience the adverse consequences of relapse and disability aggravation. Thus, it is necessary to identify sensitive and reliable biomarkers for early prognosis. This study investigated whether…
read more here.
Keywords:
hcy;
hcy level;
prognosis;
relapse ... See more keywords